BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15814571)

  • 1. Analysis of the in vivo functions of Mrp3.
    Belinsky MG; Dawson PA; Shchaveleva I; Bain LJ; Wang R; Ling V; Chen ZS; Grinberg A; Westphal H; Klein-Szanto A; Lerro A; Kruh GD
    Mol Pharmacol; 2005 Jul; 68(1):160-8. PubMed ID: 15814571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.
    Zelcer N; van de Wetering K; de Waart R; Scheffer GL; Marschall HU; Wielinga PR; Kuil A; Kunne C; Smith A; van der Valk M; Wijnholds J; Elferink RO; Borst P
    J Hepatol; 2006 Apr; 44(4):768-75. PubMed ID: 16225954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Function of Multidrug Resistance-associated Protein 3 in the Transport of Bile Acids under Normal Physiological and Lithocholic Acid-induced Cholestasis Conditions.
    Wang W; Zeng S; Hu M; Liu Z; Gong L
    Curr Drug Metab; 2021; 22(5):353-362. PubMed ID: 33461458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis.
    Teng S; Piquette-Miller M
    Br J Pharmacol; 2007 Jun; 151(3):367-76. PubMed ID: 17435798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.
    Inokuchi A; Hinoshita E; Iwamoto Y; Kohno K; Kuwano M; Uchiumi T
    J Biol Chem; 2001 Dec; 276(50):46822-9. PubMed ID: 11590139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
    Zelcer N; Saeki T; Bot I; Kuil A; Borst P
    Biochem J; 2003 Jan; 369(Pt 1):23-30. PubMed ID: 12220224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
    Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
    J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.
    Bohan A; Chen WS; Denson LA; Held MA; Boyer JL
    J Biol Chem; 2003 Sep; 278(38):36688-98. PubMed ID: 12837754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.
    Fernández-Barrena MG; Monte MJ; Latasa MU; Uriarte I; Vicente E; Chang HC; Rodriguez-Ortigosa CM; Elferink RO; Berasain C; Marin JJ; Prieto J; Ávila MA
    J Hepatol; 2012 Feb; 56(2):367-73. PubMed ID: 21756856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
    Bodo A; Bakos E; Szeri F; Varadi A; Sarkadi B
    J Biol Chem; 2003 Jun; 278(26):23529-37. PubMed ID: 12704183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ABCC3 (MRP3) by pregnane X receptor activators.
    Teng S; Jekerle V; Piquette-Miller M
    Drug Metab Dispos; 2003 Nov; 31(11):1296-9. PubMed ID: 14570758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRP2 and 3 in health and disease.
    Borst P; Zelcer N; van de Wetering K
    Cancer Lett; 2006 Mar; 234(1):51-61. PubMed ID: 16387425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids.
    McCarthy TC; Li X; Sinal CJ
    J Biol Chem; 2005 Jun; 280(24):23232-42. PubMed ID: 15824121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance-associated proteins 3, 4, and 5.
    Borst P; de Wolf C; van de Wetering K
    Pflugers Arch; 2007 Feb; 453(5):661-73. PubMed ID: 16586096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
    Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of multidrug resistance-associated protein 3 (mrp3/abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine.
    Kitamura Y; Kusuhara H; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Feb; 332(2):659-66. PubMed ID: 19889793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis.
    Mennone A; Soroka CJ; Cai SY; Harry K; Adachi M; Hagey L; Schuetz JD; Boyer JL
    Hepatology; 2006 May; 43(5):1013-21. PubMed ID: 16628672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2).
    Chu XY; Strauss JR; Mariano MA; Li J; Newton DJ; Cai X; Wang RW; Yabut J; Hartley DP; Evans DC; Evers R
    J Pharmacol Exp Ther; 2006 May; 317(2):579-89. PubMed ID: 16421286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway.
    Chai J; He Y; Cai SY; Jiang Z; Wang H; Li Q; Chen L; Peng Z; He X; Wu X; Xiao T; Wang R; Boyer JL; Chen W
    Hepatology; 2012 May; 55(5):1485-94. PubMed ID: 22105759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.